Differential expression of WT-1 in serous carcinomas in the peritoneum with or without associated serous carcinoma in endometrial polyps

American Journal of Surgical Pathology

Volumn 29, Issue 8, 2005, Pages 1074-1078

  Euscher, Elizabeth D ^a,b   Malpica, Anais ^a   Deavers, Michael T ^a   Silva, Elvio G ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Endometrial polyp; Immunohistochemistry; Ovary; Peritoneum; Serous carcinoma; Uterus; WT 1

Indexed keywords

ANTIBODY; WT1 PROTEIN;

ARTICLE; CARCINOMA; CLINICAL ARTICLE; ENDOMETRIUM POLYP; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY; OVARY CARCINOMA; PATHOGENESIS; PERITONEUM; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEROUS CARCINOMA; UTERUS; UTERUS CARCINOMA;

CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS, SECOND PRIMARY; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; POLYPS; UTERINE NEOPLASMS; WT1 PROTEINS;

EID: 22944470552     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Acs G, Pasha T, Zhang PJ. WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium. Int J Gynecol Pathol. 2004;23: 110-118.
2. Al-Hussaini M, Stockman A, Foster H, et al. WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma. Histopathology. 2004;44: 109-115.
3. Baergen RN, Warren CD, Isacson C, et al. Early uterine serous carcinoma: clonal origin of extrauterine disease. Int J Gynecol Pathol. 2001;20:214-219.
4. Bloss JD, Liao SY, Buller RE, et al. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol. 1993;50:347-351.
5. Carcangiu ML, Chambers JT. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol. 1992;47:298-305.
6. Carcangiu ML, Tan LK, Chambers JT. Stage 1A uterine serous carcinoma: a study of 13 cases. Am J Surg Pathol. 1997;21:1507-1514.
7. Cass I, Baldwin RL, Fasylova E, et al. Allelotype of papillary serous peritoneal carcinomas. Gynecol Oncol. 2001;82:69-76.
8. Egan J, Ionexcu M, Eapen E, et al. Differential expression of WT1 and p53 in serous and endometrioid carcinomas of the endometrium. Int J Gynecol Pathol. 2004;23:119-122.
9. Goldstein NS, Uzieblo A. WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas. Am J Clin Pathol. 2002;117:541-545.
10. Goldstein NS, Bassi D, Uzieblo A. WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms. Am J Clin Pathol. 2001;116:246-252.
11. Gray CA, Bartol FF, Tarleton BJ, et al. Developmental biology of uterine glands. Biol Reprod. 2001;65:1311-1323.
12. Halperin R, Zehavi S, Hadas E, et al. Immunohistochemical comparison of primary peritoneal and primary ovarian serous papillary carcinoma. Int J Gynecol Pathol. 2001;20:341-345.
13. Hashi A, Yuminamochi T, Murata SI, et al. Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum. Int J Gynecol Pathol. 2003;22:374-377.
14. Kiyokawa T, Kanetsuna Y, Harada T, et al. WT-1 expression in ovarian epithelial tumors and endometrial serous carcinoma. Mod Pathol. 2004; 17:837A.
15. Lee KR, Belinson JL. Recurrence in noninvasive endometrial carcinoma: relationship to uterine papillary serous carcinoma. Am J Surg Pathol. 1991;15:965-973.
16. Lee BH, Hecht JL, Pinkus JL, et al. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids. Am J Clin Pathol. 2002;117:745-750.
17. Levenback C, Burke TW, Silva E, et al. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC). Gynecol Oncol. 1992;46:317-321.
18. Little M, Holmes G, Walsh P. WT1: what has the last decade told us? Bioessays. 1999;21:191-202.
19. Malpica A, Deavers MT, Lu K, et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol. 2004;28:496-504.
20. Muto MG, Welch WR, Mok SC, et al. Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res. 1995;55:490-492.
21. Nishimura M, Wakabayashi M, Hashimoto T, et al. Papillary serous carcinoma of the peritoneum: analysis of clonality of peritoneal tumors. J Gastroenterol. 2000;35:540-547.
22. Schedl A, Hastie N. Multiple roles for the Wilms' tumour suppressor gene, WT1 in genitourinary development. Mol Cell Endocrinol. 1998; 140:65-69.
23. Shimizu M, Toki T, Takagi Y, et al. Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors. Int J Gynecol Pathol. 2000;19:158-163.
24. Schorge JO, Miller YB, Qi LJ, et al. Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum. Gynecol Oncol. 2000;76: 369-372.
25. Sherman ME, Bitterman P, Rosenshein NB, et al. Uterine serous carcinoma: a morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol. 1992;16:600-610.
26. Silva EG, Jenkins R. Serous carcinoma in endometrial polyps. Mod Pathol. 1990;3:120-128.
27. Soslow RA, Pirog E, Isacson C. Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis. Am J Surg Pathol. 2000;24: 726-732.
28. Sung CJ, Quddus MR, Eklund J, et al. Can the pattern of WT-1 expression reliably distinguish between synchronicity and metastasis in endometrioid and serous carcinomas of the Mullerian system? Mod Pathol. 2004;17:903A.
29. Suzuki M, Ohwada M, Kanai N, et al. Rapid death following papillary serous carcinoma of the endometrium without myometrial invasion. Oncol Rep. 1999;6:1009-1012.
30. Truong LD, Maccato ML, Awalt H, et al. Serous surface carcinoma of the peritoneum: a clinicopathologic study of 22 cases. Hum Pathol. 1990;2:99-110.
31. Tsao SW, Mok CH, Knapp RC, et al. Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas. Gynecol Oncol. 1993;48:5-10.
32. Zhang Q, Wright T, Alexis D, et al. Differential expression of WT-1 in uterine serous and endometrioid carcinoma. Mod Pathol. 2003;16:988A.